A forum for researchers, students and applicants in the field of cyclodextrin technology
Combination therapy has emerged as a promising strategy in cancer treatment, aiming to enhance therapeutic efficacy and overcome drug resistance.
The review focuses on pharmaceutical, endocrine disruptors, and dye molecules removal using βCD membrane. A gamut of methods and alteration
Although cross-linking with epichlorohydrin (EPC) is a process studied long time ago, however its use as a gastric solubility enhancer
An interesting patent application has been published disclosing CD-cellobiose or CD-lactose polymer for drug delivery targeted to the colon with
The MSCA-IF Polar Star project funded by the EC aimed at the development of a novel administration route for multiple
In the frame of the HypoCyclo project, cyclodextrin-based polymers (BCDPS) are aimed to be used as suitable shuttle for the
Chemotherapy is the most used method after surgery in the treatment of colon cancer. Cancer cells escape the recognition mechanism
CDs might be promising candidates for therapeutic and diagnostic purposes widely used in biomedicine. These structures can be chemically modified
Urease is a nickel-containing oligomer that can be used to catalyze the decomposition of urea. Free urease is unstable and
The polymerization of cyclodextrin (CD) with epichlorohydrin (ECH) dramatically increases the binding constant of CD to vanillin, from 55 to
